display ongoing
results: demonstrated suggested inconclusive safety concern ongoing study
multiple myeloma - 2nd line (L2)metastatic/advanced OC (mOC) - maintenance (M)
ovarian cancer (OC)metastatic/advanced OC (mOC) - maintenance (M)
rucaparib ARIEL3 ARIEL4 ATHENA-COMBO ...

Study type: